|
 Germany limits use of AstraZeneca shots
Germany will from Wednesday limit the use of AstraZeneca's COVID-19
vaccine to people aged 60 and above as well as high-priority groups
following further reports of a rare brain blood disorder.
"We have to be able trust the vaccines," Chancellor Angela Merkel
told journalists at a news conference on Tuesday. "And transparency
is the best way to deal with such a situation," she added.
Acting on advice from Germany's vaccine committee, federal and state
health ministries agreed that under 60-year-olds should only receive
the AstraZeneca vaccine if they belong to high-priority groups,
which include high-risk patients and medical workers, in
consultation with a doctor.
France's Macron to address country
French President Emmanuel Macron will deliver a televised address to
the nation on Wednesday evening, his office said, as a
fast-spreading third wave of infections threatens to overrun
hospitals.
The number of COVID-19 patients in intensive care increased by 98 on
Tuesday to breach the 5,000 threshold, the highest number this year.
Public health experts say the burden on intensive care is evidence
that the current set of restrictions do not go far enough.
Australia's vaccine roll-out misses targets
Australia has fallen far behind its target for vaccinations, figures
showed on Wednesday, with only about 670,000 people inoculated
against an initial target of 4 million by end-March.
The slow roll-out, which puts Australia behind many other developed
countries, has been blamed by the government on supply issues from
Europe, while recent floods across the east coast have slowed the
delivery of vaccines.
State governments have also complained about slower-than-expected
distribution and a lack of certainty on supplies, while local media
have reported errors by private contractors hired to assist with the
roll-out.
[to top of second column] |
 T cells induced by infection
respond to new virus variants
A critical component of the immune system known
as T cells that respond to fight infection from
the original version of the novel coronavirus
appear to also protect against three of the most
concerning new virus variants, according to a
U.S. laboratory study released on Tuesday.
Several recent studies have shown that certain variants of the novel
coronavirus can undermine immune protection from antibodies and
vaccines.
But antibodies may not tell the whole story, according to the study
by researchers at the National Institute of Allergy and Infectious
Diseases. T cells appear to play an important additionally
protective role.
Data withheld from WHO team, says Tedros
Data was withheld from World Health Organization investigators who
travelled to China to research the origins of the epidemic, WHO
Director-General Tedros Adhanom Ghebreyesus said on Tuesday.
The United States, the European Union and other Western countries
immediately called for China to give "full access" to independent
experts to all data about the original outbreak in late 2019.
One of the team’s investigators has already said China refused to
give raw data on early COVID-19 cases to the WHO-led team,
potentially complicating efforts to understand how the global
pandemic began.
(Compiled by Linda Noakes)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content
 |
